Hematologic
A Phase 1/2, Dose-finding Study Investigating the Safety and Efficacy of Pirtobrutinib in Adults with Immune Thrombocytopenia
- Details
ClinicalTrials.gov ID:
NCT06721013
Diagnosis Type:
NA
USOR Number:
- Address
,
P: